- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01591603
Comparison of Perineural Catheter Depth for the Continuous Popliteal Nerve Block Using Ultrasound Guidance and Dermabond
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Traditionally for the lower extremity, peripheral nerve catheters have been threaded greater than or equal to 5 centimeters past the tip of the Tuohy needle. The major rational for this practice is to reduce dislodgement. However, the greater the distance that a catheter is advanced, the greater the risk of contacting undesired structures, kinking, looping and knotting. For the continuous popliteal nerve block, the catheter is threaded perpendicular to the course of the nerve. This could result in the tip of the catheter being a significant distance from the targeted nerve which may lead to a decrease in the success rate or efficacy of the block.
Greater efficacy may be seen if the needle is closer to its target. This may be quantified by documenting a faster onset of motor and sensory changes and/or a lower catheter infusion rate required to maintain pain control. The study will investigate the difference in success rate between popliteal peripheral nerve catheters placed at 1 centimeter compared to 5 centimeters past the tip of a Tuohy needle.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Tennessee
-
Nashville, Tennessee, United States, 37232
- Vanderbilt University Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Will be having a popliteal nerve blocks
- Do not meet any of the exclusion criteria listed below.
Exclusion Criteria:
- < 18 years old
- BMI > 35
- Pregnant patients
- Diabetes mellitus or patients with known neuropathy
- Amputations & polytrauma patients
- Patients allergic to local anesthetics
- Chronic Pain patients
- Patients in whom communication is a problem
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Group 2
|
A Tuohy needle will be advanced in-plane with the bevel cephalad to a point that lies between the tibial and common peroneal branches of the sciatic nerve.
The catheter will be advanced 5 cm past the tip of the Tuohy
Other Names:
|
|
Experimental: Group 1
|
A Tuohy needle will be advanced in-plane with the bevel cephalad to a point that lies between the tibial and common peroneal branches of the sciatic nerve.
The catheter will be advanced 1 cm past the tip of the Tuohy
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Peripheral block score (PBS).
Time Frame: 10, 20, and 30 minutes after intervention
|
The extent of popliteal nerve blockade will be captured with four sensory groups (sural, superficial peroneal, tibial, and deep peroneal) and three motor groups (superficial peroneal, tibial, and deep peroneal).
For each group, a score of 0, 1, or 2 will be assigned based on complete, partial, or no blockade, respectively.
The peripheral block score (PBS) outcome variable will be based on the sum of these values and will range from 0 to 14.
|
10, 20, and 30 minutes after intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain score
Time Frame: Arrival to PACU (Immediately after surgery, approximately 3-5 hours after intervention)
|
The investigators will examine the difference in the pain scores (0-10 numeric rating scale) between the two groups.
|
Arrival to PACU (Immediately after surgery, approximately 3-5 hours after intervention)
|
|
Analgesia failure rate
Time Frame: Arrival to PACU (Immediately after surgery, approximately 3-5 hours after intervention)
|
The investigators will examine the difference in analgesia failure rates in the PACU.
Analgesia failure is defined as the failure of a rescue bolus (to treat patient pain).
|
Arrival to PACU (Immediately after surgery, approximately 3-5 hours after intervention)
|
|
Catheter dislodgement rates
Time Frame: Arrival to PACU (Immediately after surgery, approximately 3-5 hours after intervention)
|
The investigators will examine the difference in the catheter dislodgement rates.
|
Arrival to PACU (Immediately after surgery, approximately 3-5 hours after intervention)
|
|
Difference in total opioid usage
Time Frame: Length of Stay In PACU (Approximately 5-7 hours after intervention)
|
The investigators will examine the difference in the total opioid usage.
We will compare medications separately and in total equivalent units (using an opioid conversion table).
|
Length of Stay In PACU (Approximately 5-7 hours after intervention)
|
|
Degree of Doppler color agitation
Time Frame: Immediately after intervention
|
The investigators will examine the relationship between the degree of Doppler color agitation (evaluated at the time the catheter is placed) and block success (i.e., the outcome in the primary analysis).
Degree of agitation color will be defined as the percentage of nerve covered during the color agitation.
|
Immediately after intervention
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Clifford Bowens, M.D., Vanderbilt University Medical Center
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 120382
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Neuromuscular Inhibition
-
Örebro University, SwedenKarolinska InstitutetCompletedMaladaptive Anger InhibitionSweden
-
University Hospital, GenevaCompletedInhibitionSwitzerland
-
Mahidol UniversityCompletedOvulation InhibitionThailand
-
National Institute of Neurological Disorders and...CompletedInterhemispheric InhibitionUnited States
-
AstraZenecaTerminatedThrombin InhibitionUnited States
-
Funch-Jensen, Peter, M.D., D.M.Sc.Medtronic - MITGCompletedPain | Obesity | Surgery | Neuromuscular InhibitionDenmark
-
BayerCompletedOvulation InhibitionGermany, Netherlands
-
AstraZenecaPOZENCompletedPlatelet InhibitionUnited States
-
University Hospital, Basel, SwitzerlandCompletedInhibition | Drug-Drug Interaction | InductionSwitzerland
-
BayerCompletedContraception | Ovulation Inhibition | Contraceptives, OralUnited States
Clinical Trials on 1 cm
-
Géraldine MartensCentre Hospitalier Universitaire Dinant Godinne - UCL NamurCompletedPathologic Processes | Stroke | Central Nervous System Diseases | Neurocognitive Disorders | Brain Injuries | Craniocerebral Trauma | Trauma, Nervous System | Disorder of Consciousness | Contracture | Spasticity as Sequela of Stroke | Hypertonic DisorderBelgium
-
Postgraduate Institute of Dental Sciences RohtakNot yet recruiting
-
Kythera BiopharmaceuticalsCompletedHealthy | Submental FatUnited States, Canada, Australia, United Kingdom
-
Clinical Nutrition Research Center, Illinois Institute...CompletedGlycemic ResponseUnited States
-
Zynex Monitoring SolutionsCompleted
-
Università Vita-Salute San RaffaeleActive, not recruitingGingival RecessionItaly
-
Odense University HospitalRecruitingUlcerative Colitis | Familial Adenomatous PolyposisDenmark
-
Peter GillgrenCompletedMelanoma | Surgery | Treatment Outcome
-
Karolinska InstitutetSwedish Cancer Society; Stockholm Cancer SocietyCompletedMelanoma | Surgery | Treatment Outcome
-
Veterans Medical Research FoundationNational Center for Complementary and Integrative Health (NCCIH)Completed